Skip to content

Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy

Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06582667
Acronym
PENG Block
Enrollment
100
Registered
2024-09-03
Start date
2024-09-17
Completion date
2025-04-17
Last updated
2024-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antithrombotic Therapy, Hip Fracture, PENG Block

Keywords

antithrombotic therapy, PENG block

Brief summary

PENG block will be done on patients with hip fracture either receiving antithrombotic therapy or not under ultrasound guidance

Detailed description

Patients will be randomized into two groups: Group A (Antithrombotic Therapy Group): 50 Patients on continuous antithrombotic therapy will receive BENG block. Group C (Control Group): 50 Patients without antithrombotic therapy will receive BENG block. Intervention: PENG Block: Standardized administration of the PENG block will be performed by experienced anesthesiologists for both groups using ultrasound device. The patients will be subjected to standard monitoring and received nasal cannula oxygen (2 L/min). Midazolam (1-2 mg) will be administered intravenously for light sedation. Under sterile conditions, a low-frequency curvilinear probe of ultrasound (SonoSite S-Nerve Machine, Fujifilm) is initially placed in a transverse plane over the anterior inferior iliac spine, and is then rotated parallel to the pubic ramus to obtain a short-axis view of the iliopsoas muscle and tendon lying on the ramus pubic adjacent to the iliopubic eminence. After skin infiltration with 1-3 mL 1% lidocaine, a 23 G, 70 mm insulated block needle is inserted in-plane in a lateral-to- medial direction to place the tip in the musculofascial plane between the psoas tendon and the pubic ramus. A total of 20 mL 0.5% bupivacaine (AstraZeneca, EGYPT) is injected slowly in 5 mL increments with intermittent aspiration and under constant ultrasound surveillance for adequate fluid spread. Thirty minutes after the block completion, standardized endotracheal general anesthesia is induced with propofol (2-2.5 mg/kg), fentanyl (0.5-1,5 μg/kg), and atracurium (0.5 mg/kg).maintenance of anesthesia is done with sevoflurane (2-2.5%) with o2and air 60:40% Antithrombotic Management: Clear protocols for managing antithrombotic therapy in Group A will be implemented, considering perioperative bleeding risk

Interventions

PROCEDUREPENG block

US guided PENG block in hip fracture without anti thrombotic therapy

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

outcomes assessor

Intervention model description

group I: PENG block with antithrombotic therapy group II: PENG block without antithrombotic therapy

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age 65 years or older * diagnosis of hip fracture * scheduled for surgical intervention within 48 hours * Informed consent obtained.

Exclusion criteria

* Allergy to local anesthetics, * Contraindications to the PENG block * inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Hematoma Formationfirst 48 hours postinterventionThe occurrence and severity of hematomas at the PENG block site. Measurement: Regular clinical examinations and imaging studies to assess for hematoma formation.
Bloody Tab on the Needle:immediately during the procedure ( first 10 minutes after PENG block)Presence of blood on the needle during the performance of the PENG block.
Rest and mobilization pain by numerical rating scale1 hour and 6 hours after surgery, on the same day of surgery (D 0) and first day postoperative(D 1) at 8 a.m., 1 p.m. and 6 p.m.post intervention to be assessed 0-10

Secondary

MeasureTime frameDescription
- Perioperative opiate usefrom the end of surgery to 48 hours postoperativewill be calculated over 48 hours in milligrams
Incidence of Nerve Injuryafter performing the block ( 12 hours after surgery) and subsequent assessments on the next 48 hoursAny signs of sensory or motor deficits, paresthesia, or neuropathic pain related to nerve injury or compression due to hematoma formation.
length of hospital stay in daysfrom the date of admission to the date of dischargethe number of days spent in the hospital will be calculated at the date of discharge the starting day is the date of admission called day 1 and all days spent in the hospital will be counted till the day of going home and this expected to be from 3-10 days after operation
Postoperative quadriceps strengthfirst day postoperative postoperative (12 hours after surgery)Quadriceps strength is assessed using the knee extension Test and Oxford muscle strength grading with grouped scores of intact (5/5), reduced (1-4/5) and absent (0/5).
The quality of Postoperative functional recovery and the variations and differences between groups will be assessed using the validated arabic version of the quality-of-recovery 15-items score (QoR-15)On the same day of surgery ( 12 hours after surgery) and first day postoperative15 values score ranges from 0-150 ,excellent \>135, good \> 122 and \< 135, moderate \>90 and \< 121, poor \< 90

Countries

Egypt

Contacts

Primary ContactWessam El-amrawy, myself
wesam.amrawy@alexu.edu.eg01280998606
Backup Contacttarek ismail, study director
drtarek.anesth@gmail.com01001467166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026